Assure Holdings Announces Merger Agreement with Danam Health
Denver-based Assure Holdings, a provider of outsourced intraoperative neuromonitoring and remote neurology services, has announced a merger agreement with Danam Health. Under the terms of the agreement, Danam will merge with a newly formed subsidiary of Assure.
This stock-for-stock deal will see Danam become a wholly-owned subsidiary of Assure. Assure will also change its name to Danam Health Holdings Corp. The goal of this merger is for the combined company to continue operating as a Nasdaq-listed entity in the pharmaceutical and healthcare services sectors.
Both companies have structured the merger as a stock-for-stock exchange, with all outstanding equity securities of Danam exchanged for Assure common stock. Danam stockholders are expected to hold approximately 90% of the combined company, while Assure stockholders will have a 10% ownership stake.
The boards of both Assure and Danam have approved the merger, which is anticipated to close in the second quarter, pending regulatory requirements and customary closing conditions.
This merger agreement positions Assure Holdings and Danam Health for a promising future. With their combined expertise and resources, they are poised to make significant advancements in the pharmaceutical and healthcare sectors. The newly-formed company is well-positioned to meet the growing demand for high-quality pharmaceutical and healthcare services.
Disclaimer: This article is for informational purposes only and should not be considered as financial or investment advice.
Analyst comment
Positive news. The merger agreement between Assure Holdings and Danam Health is expected to result in a transformative shift for both companies. The combined entity aims to operate as a Nasdaq-listed company in the pharmaceutical and healthcare services sectors. The merger is anticipated to be completed in the second quarter, pending regulatory approvals and closing conditions. This merger positions the newly-formed company as a significant player in meeting the increasing demand for high-quality healthcare services. Market analysts are optimistic about the potential advancements and future prospects of the merged entity.
